Repronex

Description: Repronex (human menopausal gonadotropin, hMG) is used to stimulate the production of follicles/eggs in women who are unable to produce eggs for functional reasons rather than primary ovarian failure. It is also used for stimulating the development of multiple follicles as part of an assisted reproductive technology (ART) program. Each vial contains 75 IU (international units) of powdered medication to be mixed with diluent.

How It Works: Repronex is administered by subcutaneous or intramuscular injection. It promotes the development and maturation of follicles in the ovaries. Repronex is a gonadotropin that contains a combination of follicle stimulating hormone (FSH) and luteinizing hormone (LH). For additional information on administering Repronex click here .

Potential Side Effects: Side effects that may occur include: mild to moderate ovarian enlargement, ovarian cysts, nausea, vomiting, diarrhea, abdominal cramping, abdominal pain, bloating, dizziness, breast tenderness, body rash, and injection site reactions (pain, rash, swelling, irritation). The risk of ovarian hyperstimulation syndrome (OHSS) should be discussed with your physician prior to treatment. Early warning signs include severe pelvic pain, nausea, vomiting, and weight gain.

If you experience an allergic reaction: difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives; seek emergency medical attention immediately. And if at any time you experience: pain, warmth, redness, numbness, or tingling in an arm or leg; confusion, severe dizziness or severe headache, seek emergency medical attention immediately.

PLEASE NOTE: If these or any other side effects occur, contact your physician

Storage: Repronex may be stored refrigerated or at room temperature 37-77ºF. Protect from light. Use immediately after reconstitution. Discard unused material.

Written Injection Instructions